A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer
Abroad (travel likely)RecruitingPHASE2, PHASE3
Conditions
Pancreatic Ductal Adenocarcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Karmanos Cancer Center, Detroit, Michigan, United States
Contact: Principal Investigator (Anthony Shields, MD)Baylor College of Medicine, Houston, Texas, United States
Contact: Study coordinator (Shalini Makawita, MD)